Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be 12 years of age or older.~* Has a diagnosis of facial acne vulgaris with no more than two nodules on the face.~Exclusion Criteria:~* Is allergic to tetracycline-class antibiotics or to any ingredient in the study medication.~* Has a history of pseudomembranous colitis or antibiotic-associated colitis.~* Has a history of hepatitis or liver damage or renal impairment.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Doxycycline hyclate (Doryx) (Type: EXPERIMENTAL): None
- Doxycycline hyclate (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).